LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.94 | 21.74 | 66 | 6121 | 0.0108 | 0.1462 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.94 | 21.74 | 8301 | 6121 | 1.3560 | 1.0763 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 93.92 | 21.74 | 1 | 6070 | 0.0002 | -0.3154 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 93.92 | 21.74 | 12469 | 6070 | 2.0542 | 1.1853 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 93.92 | 21.74 | 71 | 6070 | 0.0117 | 0.1568 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 93.92 | 21.74 | 8099 | 6070 | 1.3343 | 1.0723 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.24 | 21.74 | 363 | 183 | 1.9774 | 1.4959 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.24 | 21.74 | 398 | 183 | 2.1681 | 1.5717 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.24 | 21.74 | 660 | 317 | 2.0769 | 1.4158 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.24 | 21.74 | 643 | 317 | 2.0234 | 1.3995 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.21 | 21.74 | 757 | 392 | 1.9311 | 1.3417 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.21 | 21.74 | 779 | 392 | 1.9872 | 1.3578 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.19 | 21.74 | 828 | 439 | 1.8824 | 1.3139 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.19 | 21.74 | 3 | 439 | 0.0068 | -0.3665 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.19 | 21.74 | 870 | 439 | 1.9779 | 1.3405 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.16 | 21.74 | 871 | 463 | 1.8786 | 1.3071 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.16 | 21.74 | 2 | 463 | 0.0043 | -0.4175 | MN20160310_N01 | E11 |